BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1402666)

  • 1. A third tal-1 promoter is specifically used in human T cell leukemias.
    Bernard O; Azogui O; Lecointe N; Mugneret F; Berger R; Larsen CJ; Mathieu-Mahul D
    J Exp Med; 1992 Oct; 176(4):919-25. PubMed ID: 1402666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two site-specific deletions and t(1;14) translocation restricted to human T-cell acute leukemias disrupt the 5' part of the tal-1 gene.
    Bernard O; Lecointe N; Jonveaux P; Souyri M; Mauchauffé M; Berger R; Larsen CJ; Mathieu-Mahul D
    Oncogene; 1991 Aug; 6(8):1477-88. PubMed ID: 1886719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
    Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
    Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias.
    Bernard O; Guglielmi P; Jonveaux P; Cherif D; Gisselbrecht S; Mauchauffe M; Berger R; Larsen CJ; Mathieu-Mahul D
    Genes Chromosomes Cancer; 1990 Jan; 1(3):194-208. PubMed ID: 1964581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
    Carlotti E; Pettenella F; Amaru R; Slater S; Lister TA; Barbui T; Basso G; Cazzaniga G; Rambaldi A; Biondi A
    Br J Haematol; 2002 Sep; 118(4):1011-8. PubMed ID: 12199779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35).
    Fitzgerald TJ; Neale GA; Raimondi SC; Goorha RM
    Blood; 1991 Nov; 78(10):2686-95. PubMed ID: 1824262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).
    Huang W; Kuang SQ; Huang QH; Dong S; Zhang T; Gu LJ; Ching LM; Chen SJ; Chang LC; Chen Z
    Cancer Genet Cytogenet; 1995 May; 81(1):76-82. PubMed ID: 7773964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
    Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
    Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia.
    Chen Q; Yang CY; Tsan JT; Xia Y; Ragab AH; Peiper SC; Carroll A; Baer R
    J Exp Med; 1990 Nov; 172(5):1403-8. PubMed ID: 2230650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
    Breit TM; Mol EJ; Wolvers-Tettero IL; Ludwig WD; van Wering ER; van Dongen JJ
    J Exp Med; 1993 Apr; 177(4):965-77. PubMed ID: 8459224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of translocation t(1;14)(p32;q11) in a T and in a B acute leukemia.
    Bernard O; Barin C; Charrin C; Mathieu-Mahul D; Berger R
    Leukemia; 1993 Oct; 7(10):1509-13. PubMed ID: 8412312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
    Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
    Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines.
    Leroy-Viard K; Vinit MA; Lecointe N; Mathieu-Mahul D; Roméo PH
    Blood; 1994 Dec; 84(11):3819-27. PubMed ID: 7949138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythroid-specific inhibition of the tal-1 intragenic promoter is due to binding of a repressor to a novel silencer.
    Courtes C; Lecointe N; Le Cam L; Baudoin F; Sardet C; Mathieu-Mahul D
    J Biol Chem; 2000 Jan; 275(2):949-58. PubMed ID: 10625632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of TAL-1 proteins in human tissues.
    Pulford K; Lecointe N; Leroy-Viard K; Jones M; Mathieu-Mahul D; Mason DY
    Blood; 1995 Feb; 85(3):675-84. PubMed ID: 7833471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia.
    Brown L; Cheng JT; Chen Q; Siciliano MJ; Crist W; Buchanan G; Baer R
    EMBO J; 1990 Oct; 9(10):3343-51. PubMed ID: 2209547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints.
    Raghavan SC; Kirsch IR; Lieber MR
    J Biol Chem; 2001 Aug; 276(31):29126-33. PubMed ID: 11390401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
    Goldfarb AN; Greenberg JM
    Leuk Lymphoma; 1994 Jan; 12(3-4):157-66. PubMed ID: 8167548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rhom-2 expression does not always correlate with abnormalities on chromosome 11 at band p13 in T-cell acute lymphoblastic leukemia.
    Fitzgerald TJ; Neale GA; Raimondi SC; Goorha RM
    Blood; 1992 Dec; 80(12):3189-97. PubMed ID: 1281693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
    Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
    Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.